Free Trial

Oracle (ORCL) Stock Forecast & Price Target

Oracle logo
$145.88 -1.92 (-1.30%)
Closing price 03:59 PM Eastern
Extended Trading
$145.76 -0.12 (-0.08%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oracle - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
12
Buy
16

Based on 28 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 28 analysts, 12 have given a hold rating, 15 have given a buy rating, and 1 has given a strong buy rating for ORCL.

Consensus Price Target

$179.20
22.84% Upside
According to the 28 analysts' twelve-month price targets for Oracle, the average price target is $179.20. The highest price target for ORCL is $220.00, while the lowest price target for ORCL is $130.00. The average price target represents a forecasted upside of 22.84% from the current price of $145.88.
Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

Sign Up

ORCL Analyst Ratings Over Time

TypeCurrent Forecast
3/27/24 to 3/27/25
1 Month Ago
2/26/24 to 2/25/25
3 Months Ago
12/28/23 to 12/27/24
1 Year Ago
3/28/23 to 3/27/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
18 Buy rating(s)
17 Buy rating(s)
14 Buy rating(s)
Hold
12 Hold rating(s)
10 Hold rating(s)
10 Hold rating(s)
9 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$179.20$182.73$181.48$130.76
Forecasted Upside22.84% Upside8.44% Upside7.41% Upside4.38% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Remove Ads

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oracle Stock vs. The Competition

TypeOracleComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.61
2.68
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside22.84% Upside760.83% Upside17.91% Upside
News Sentiment Rating
Positive News

See Recent ORCL News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/19/2025Stephens
4 of 5 stars
Brett Huff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$167.00+11.72%
3/12/2025Citigroup
3 of 5 stars
Tyler Radke
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$194.00 ➝ $160.00+5.27%
3/11/2025UBS Group
4 of 5 stars
 Reiterated RatingMarket Perform ➝ Market Perform
3/11/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Jaluria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetSector Perform ➝ Sector Perform$145.00-0.77%
3/11/2025DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gil Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$150.00 ➝ $150.00+5.18%
3/11/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mark Murphy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$140.00 ➝ $135.00-4.12%
3/11/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jackson Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.00+41.95%
3/11/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Blakey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$214.00 ➝ $175.00+25.43%
3/11/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Bachman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetMarket Perform ➝ Market Perform$205.00 ➝ $175.00+17.55%
3/11/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Raimo Lenschow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$212.00 ➝ $202.00+35.69%
3/11/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$210.00 ➝ $190.00+27.63%
3/11/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$195.00 ➝ $175.00+17.55%
3/11/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kirk Materne
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$200.00 ➝ $185.00+24.27%
3/11/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Weiss
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$175.00 ➝ $170.00+14.19%
3/11/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Reback
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$175.00 ➝ $150.00+0.76%
3/5/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Difucci
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$220.00 ➝ $220.00+38.91%
3/3/2025Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. White
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
1/22/2025JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Walravens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$205.00 ➝ $205.00+11.77%
12/10/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
12/10/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$185.00 ➝ $210.00+10.21%
12/5/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$190.00 ➝ $220.00+16.90%
9/30/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$201.00 ➝ $202.00+19.71%
9/16/2024Melius Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/10/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform
9/10/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$165.00 ➝ $180.00+28.65%
6/18/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$145.00 ➝ $159.00+11.83%
6/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$150.00 ➝ $165.00+18.39%
3/13/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$144.00 ➝ $155.00+21.42%
3/13/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$115.00 ➝ $130.00+1.83%
3/12/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Naji
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
12/22/2023Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
12/12/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$140.00 ➝ $130.00+12.96%
11/13/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
9/21/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$82.50 ➝ $110.00-2.54%
9/14/2023DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$125.00+11.77%
6/13/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:20 PM ET.


Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, March 26, 2025. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Oracle:

  • Oracle has recently increased its quarterly dividend from $0.40 to $0.50, reflecting a commitment to returning value to shareholders. This represents a 1.35% dividend yield, which can be attractive for income-focused investors.
  • The stock is currently trading at $147.18, which may present a buying opportunity for investors looking for potential growth, especially considering the company's market cap of approximately $411.65 billion.
  • Analysts have a consensus rating of "Moderate Buy" for Oracle, with a target price averaging around $179.20, indicating potential upside from the current trading price.
  • Oracle's revenue has shown a year-over-year increase of 6.4%, demonstrating growth in its business operations, which can be a positive indicator for future performance.
  • Insider ownership stands at 42.20%, suggesting that executives have a significant stake in the company, which can align their interests with those of shareholders and potentially lead to better decision-making.

Oracle
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Oracle for these reasons:

  • Oracle's recent earnings report showed a miss on EPS estimates, with reported earnings of $1.47 compared to the consensus estimate of $1.49, which may raise concerns about the company's short-term profitability.
  • The stock has experienced volatility, recently trading down by 3.9%, which could indicate market uncertainty and potential risks for investors looking for stability.
  • With a debt-to-equity ratio of 5.65, Oracle has a high level of debt compared to its equity, which can pose risks, especially in a rising interest rate environment.
  • Some analysts have issued lower price targets, with Stifel Nicolaus reducing their target from $175.00 to $150.00, suggesting that there may be differing opinions on the stock's future performance.
  • 42.44% of Oracle's stock is owned by institutional investors, which can lead to increased volatility if these investors decide to sell their positions, impacting the stock price negatively.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 28 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $179.20, with a high forecast of $220.00 and a low forecast of $130.00.

28 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last year. There are currently 12 hold ratings, 15 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 22.84% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 3 upgrades and 1 downgrade by analysts.

Analysts like Oracle less than other "computer and technology" companies. The consensus rating score for Oracle is 2.61 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how ORCL compares to other companies.


This page (NYSE:ORCL) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners